Evidence map›Paper›PMID 31832295›Full record

Article3 Biotech2020

Evidence of mutations conferring resistance to clarithromycin in wastewater and activated sludge.

Anna Gnida, Ewa Felis, Aleksandra Ziembińska-Buczyńska, Aneta Łuczkiewicz, Joanna Surmacz-Górska, Krystyna Olańczuk-Neyman

Open access · bronzeAbstract read
In one paragraph

Article in 3 Biotech, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Prevalence and Risk Factors Associated withActa gastroenterologica Latinoamericana
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anna Gnida1Department of Environmental Biotechnology, Faculty of Energy and Environmental Engineering, Silesian University of Technology, Akademicka 2A, 44-100 Gliwice, Poland.ORCID 0000-0002-0293-0602
Ewa Felis1Department of Environmental Biotechnology, Faculty of Energy and Environmental Engineering, Silesian University of Technology, Akademicka 2A, 44-100 Gliwice, Poland.ORCID 0000-0002-9320-8702
Aleksandra Ziembińska-Buczyńska1Department of Environmental Biotechnology, Faculty of Energy and Environmental Engineering, Silesian University of Technology, Akademicka 2A, 44-100 Gliwice, Poland.ORCID 0000-0002-5203-2667
Aneta Łuczkiewicz2Department of Water and Wastewater Technology, Faculty of Civil and Environmental Engineering, Gdańsk University of Technology, G. Narutowicza 11/12, 80-952 Gdańsk, Poland.ORCID 0000-0002-4145-3036
Joanna Surmacz-Górska1Department of Environmental Biotechnology, Faculty of Energy and Environmental Engineering, Silesian University of Technology, Akademicka 2A, 44-100 Gliwice, Poland.ORCID 0000-0002-1805-2189
Krystyna Olańczuk-Neyman2Department of Water and Wastewater Technology, Faculty of Civil and Environmental Engineering, Gdańsk University of Technology, G. Narutowicza 11/12, 80-952 Gdańsk, Poland.
Silesian University of Technology · PLGdańsk University of Technology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of clarithromycin in wastewater samples and of the activated sludge bacteria possibly resistant to this pharmaceutical was the object of the study. Samples of wastewater or activated sludge were taken from a municipal wastewater treatment plant in summer and winter and characterised regarding their clarithromycin concentrations and the presence of nucleic acid fragments (Cla-sequences) known to be responsible for clarithromycin resistance in

Indexed as

Activated sludgeClarithromycinClarithromycin resistance mutationNitrifying bacteriaWastewater treatment

Identifiers

PMID31832295
PMCPMC6884605
OpenAlexW2991581712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.